Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wilfried De Backer
With
UCB Pharma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with asthma as defined by the current Global INitiative for Asthma (GINA) guidelines:
Male or female patients aged ≥18 years
Patients with a documented positive response to the reversibility test within the 12 months preceding the screening visit or performed at screening visit after a wash-out of 2 days for long acting β2 agonists or a documented positive response to the methacholine challenge test
Patients with a co-operative attitude and ability to be trained to correctly use the pressurized Metered Dose Inhaler (pMDI)
Written informed consent obtained
You may not be if
Pregnant or lactating females or females at risk of pregnancy
Inability to carry out pulmonary function testing
Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) as defined by the current Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines
History of near fatal asthma
Hospitalization due to asthma or symptomatic infection of the airways in the previous 8 weeks
Current smokers or recent (less than one year) ex-smokers, defined as smoking at least 10 cigarettes/day
Patients with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially compromise the results or interpretation of the study
Patients with a QTc interval (Bazett's formula) at the screening visit Electrocardiogram (ECG) test \>450 msec
Cancer or any other chronic disease with poor prognosis and /or affecting patient status
History of alcohol or drug abuse
Allergy, sensitivity or intolerance to study drugs and/or study drug formulation ingredients
Patients unlikely to comply with the protocol or unable to understand the nature, scope and possible consequences of the study
Patients who received any investigational new drug within the last 8 weeks prior to the screening visit
Patients treated with any non-permitted concomitant medication
Clareo Health | Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients
